Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion type Assertion NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_head.
- NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion description "[Furthermore, we found that L1, ezrin and phosphorylated p65 are co-expressed at the invasive front in human CRC tissue, indicating that L1-mediated activation of NF-kappaB signaling involving ezrin is a major route of CRC progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_provenance.
- NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion evidence source_evidence_literature NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_provenance.
- NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion SIO_000772 20501702 NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_provenance.
- NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion wasDerivedFrom befree-2016 NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_provenance.
- NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_assertion wasGeneratedBy ECO_0000203 NP814549.RAVgdpb1oGVRMrK_u0sewAKuhqYCao2R_4L1aq0Q3pAlA130_provenance.